Athira Pays $4 Million To Resolve Research Misconduct Allegations

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Athira To Pay Over $4 Million To Resolve False Claims Allegations Stemming From Research Misconduct

Dennis Tosh

January 8, 2025 at 01:17 PM EST

A pharmaceutical company has agreed to pay more than $4 million to resolve allegations that it violated the False Claims Act by using falsified academic research to obtain grants from the National Institutes of Health (NIH) and failing to report allegations of research misconduct to NIH and the Department of Health and Human Services (HHS) Office of Research Integrity in grant... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Athira To Pay Over $4 Million To Resolve False Claims Allegations Stemming From Research Misconduct

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT